Psychopharmacogenomic Testing

GeneSight Psychotropic is a pharmacogenomic test (multigene panel) that uses a proprietary algorithm to evaluate pharmacokinetic and pharmacodynamic relationships, resulting in drug recommendations or warnings for certain neuropsychiatric medications. Testing can potentially help guide efficient medication selection or dosing for multiple psychiatric conditions.

The GeneSight test must be ordered by your nurse practitioner. The test is a simple cheek swab taken in your healthcare provider’s office or can be sent by your nurse practitioner to be taken in the convenience of your home.

​

*Shine Behavioral Health does not charge for pharmacogenomic testing.  You must schedule and complete an initial assessment with a nurse practitioner to discuss whether this testing is right for you followed by a second appointment to interpret results. As only a small population of patients are expected to have genetic phenotypes that would necessitate medication changes, choosing medications based on health history and symptoms should still be the standard initial approach.

​